// App-Quantinova.ai

3171 : Analysis of "drug addiction" mechanisms in the drug-resistant ROS1-rearranged cancer cells

Researchers

Presenter

  • Hayato Ogura

Principal Investigators

  • Jun Adachi

  • Takeshi Tomonaga

  • Naoya Fujita

  • Ryohei Katayama

Medical Centers

  • The Cancer Chemotherapy Ctr., JFCR, Tokyo, Japan

  • Lab. of Proteome Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Anaplastic lymphoma Kinase

Drug/Treatment

  • Cabozantinib

  • Crizotinib

  • Lorlatinib

  • L-Tyrosine

  • Prulifloxacin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved